Levorphanol
Levo-dromoran (levorphanol) is a small molecule pharmaceutical. Levorphanol was first approved as Levo-dromoran on 1991-12-19. It is used to treat pain in the USA. The pharmaceutical is active against mu-type opioid receptor. In addition, it is known to target glutamate receptor ionotropic, NMDA 2C.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
levorphanol tartrate | ANDA | 2022-11-01 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pain | EFO_0003843 | D010146 | R52 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code | Description |
---|---|
J1960 | Injection, levorphanol tartrate, up to 2 mg |
Clinical
Clinical Trials
59 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | — | — | 1 | 5 | 2 | 8 |
Anesthesia | D000758 | — | — | — | 2 | 2 | 4 | ||
Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | 1 | 1 | 2 | — | 3 |
Postoperative pain | D010149 | G89.18 | — | — | — | 2 | 1 | 3 | |
Pulpitis | D011671 | EFO_1001139 | K04.0 | — | — | — | 1 | 2 | 3 |
Local anesthesia | D000772 | — | 1 | 1 | 1 | — | 3 | ||
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 1 | 1 | 1 | — | 2 |
Nerve block | D009407 | — | — | — | 1 | 1 | 2 | ||
Spinal anesthesia | D000775 | — | — | — | 2 | — | 2 | ||
Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | 2 | — | 2 |
Show 15 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Low back pain | D017116 | HP_0003419 | M54.5 | 1 | 1 | — | — | — | 1 |
Intervertebral disc degeneration | D055959 | HP_0008419 | 1 | 1 | — | — | — | 1 | |
Ischemic stroke | D000083242 | — | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypotension | D007022 | EFO_0005251 | I95 | — | — | — | — | 1 | 1 |
Anterior cruciate ligament injuries | D000070598 | — | — | — | — | 1 | 1 | ||
Orthodontic anchorage procedures | D052280 | — | — | — | — | 1 | 1 | ||
Bursitis | D002062 | EFO_1000941 | M71.9 | — | — | — | — | 1 | 1 |
Edema | D004487 | R60.9 | — | — | — | — | 1 | 1 | |
Trismus | D014313 | — | — | — | — | 1 | 1 | ||
Chronic renal insufficiency | D051436 | N18 | — | — | — | — | 1 | 1 | |
Neuromuscular blockade | D019148 | — | — | — | — | 1 | 1 | ||
Vibration | D014732 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | LEVORPHANOL |
INN | levorphanol |
Description | Levorphanol is a morphinane alkaloid. |
Classification | Small molecule |
Drug class | narcotic antagonists/agonists (morphinan derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13 |
Identifiers
PDB | — |
CAS-ID | 77-07-6 |
RxCUI | 6378 |
ChEMBL ID | CHEMBL592 |
ChEBI ID | 6444 |
PubChem CID | 5359272 |
DrugBank | DB00854 |
UNII ID | 27618J1N2X (ChemIDplus, GSRS) |
Target
Alternate
GRIN2C
GRIN2C
Organism
Homo sapiens
Gene name
GRIN2C
Gene synonyms
NMDAR2C
NCBI Gene ID
Protein name
glutamate receptor ionotropic, NMDA 2C
Protein synonyms
GluN2C(alt_5'UTR_77nt), GluN2C(alt_5'UTR_87nt), GluN2C(del_e2), GluN2C-b alternative isoform, Glutamate [NMDA] receptor subunit epsilon-3, glutamate receptor, ionotropic, N-methyl D-aspartate 2C, N-methyl D-aspartate receptor subtype 2C, N-methyl-D-aspartate receptor subunit 2C, NMDAR2C, NR2C, putative NMDtranscript(altAcc_e11), putative NMDtranscript(altDon_e4), putative NMDtranscript(del_e4)
Uniprot ID
Mouse ortholog
Grin2c (14813)
glutamate receptor ionotropic, NMDA 2C (Q01098)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 863 documents
View more details
Safety
Black-box Warning
Black-box warning for: Levorphanol tartrate
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
266 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more